Benign paroxysmal positional vertigo (BPPV) is a common vestibular disorder characterized by episodic vertigo. BPPV primarily affects older adults. Thus, understanding the potential relationship between BPPV and osteoporosis is clinically important. We performed a systematic search of MEDLINE (PubMed), Embase, and Cochrane Library databases for studies on the risk of osteoporosis between BPPV (+) and BPPV (−) groups up until 17 April 2023. We compared osteoporosis prevalence between groups and performed subgroup analyses for male, female, and older patients (aged ≥ 55 years). The 12 studies included 32,460 patients with BPPV and 476,304 controls. Pooled analysis showed that the BPPV (+) group had a significantly higher osteoporosis risk than the control group (odds ratio [OR], 1.73; 95% confidence interval [CI], 1.45–2.06; p < 0.01). Subgroup analyses also presented similar trends as male (OR, 2.41; 95% CI, 1.18–4.90; p = 0.02), female (OR, 2.14; 95% CI, 1.57–2.92; p < 0.001), and older patient subgroups (OR, 1.91; 95% CI, 1.47–2.49; p < 0.01) showed a higher osteoporosis risk in the BPPV (+) group than in the control group. This meta-analysis supports the hypothesis that patients with BPPV have a higher osteoporosis prevalence than those without.
Background/Objectives: We investigated: (1) differences in CI-aided thresholds and speech perception scores among cochlear implant manufacturers and (2) the relationship between CI-aided thresholds and speech perception. Methods: We analyzed exploratory data from NYU and a confirmatory data set of 120 CI-aided audiograms from the ASAN clinic. CI-aided soundfield evaluations were compared between manufacturers (Cochlear, Advanced Bionics, MED-EL) using 5- and 6-pure-tone average thresholds; percentage of patients with average thresholds above 35 dB HL; speech perception scores; and correlations between thresholds and speech perception. Results: Compared to Cochlear users, MED-EL and Advanced Bionics users had significantly higher (poorer) pure-tone averages (26.7 dB HL for Cochlear vs. 30.0 dB HL for AB and 34.6 dB HL for MED-EL at NYU; 29.0 dB HL for Cochlear vs. 36.5 dB HL for MED-EL at ASAN), and higher incidence of 5- or 6-PTAs above 35 dB HL (1.6% vs. 23.4%/47.1% at NYU; 11.2% vs. 60.0% at ASAN). Word and sentence scores were significantly higher for the Cochlear group when compared to the MED-EL group. Speech scores were higher for manufacturers that recommend the use of behaviorally-measured T-levels (Cochlear) rather than estimated T-levels (AB and MED-EL). Significant negative correlations existed between CI-aided thresholds and speech scores. Conclusions: Significant differences in CI-aided thresholds and speech perception were observed between manufacturers, potentially related to brand-specific T-level programming approaches.
Objective: To evaluate the audiologic outcomes after cochlear implantation (CI) in prelingually deaf children with comorbid disorders. Study Design: Retrospective study. Setting: Tertiary care academic center. Patients: We enrolled 85 deaf children (111 ears) with comorbid disorders who underwent CI surgery. Main Outcomes and Measures: We selected the most common comorbid disorder and compared the categories of auditory performance (CAP) scores of each comorbidity group with those of the control group. Combined cochlear anomalies were also evaluated using temporal bone computed tomography. Results: The most common comorbid disorder was CHARGE syndrome (n = 17), followed by developmental delay (n = 13), valvular heart disease (including septal defect) (n = 13), Waardenburg syndrome (n = 8), Down syndrome (n = 6), cerebral palsy (n = 5), and cryptorchidism (n = 5). The CAP scores differed significantly between all the groups and the control group after 6 months (p < 0.001). The differences in the CHARGE syndrome (p = 0.004), cerebral palsy (p = 0.001), and Down syndrome (p = 0.004) groups remained significant 2 years after CI. When comparing the presence or absence of anomalies within the syndromic and nonsyndromic groups, significantly poorer outcomes exist when cochlear anomalies with absent modiolus or cochlear nerve deficits were observed, regardless of the presence of syndromic disorders. Conclusion: Compared with those in the control group, the CAP scores in the group with coexisting disabilities increased over time, but their final scores were relatively lower. Combined disabilities as well as the absent modiolus and cochlear nerve deficit may be clinical markers for poor CAP scores.